VALINK THERAPEUTICS
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.
VALINK THERAPEUTICS
Social Links:
Industry:
Health Care Therapeutics Wellness
Founded:
2021-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.valinktx.com
Total Employee:
11+
Status:
Active
Total Funding:
125 K USD
Current Employees Featured
Founder
Investors List
Y Combinator
Y Combinator investment in Pre Seed Round - Valink Therapeutics
Official Site Inspections
http://www.valinktx.com Semrush global rank: 12.01 M Semrush visits lastest month: 136
- Host name: 198.202.211.1
- IP address: 198.202.211.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Valink Therapeutics"
Valink | Building new cures from known antibodies
Rapid Design. The discovery of bsADCs is held back by an inability to rapidly generate and screen new therapeutic candidates. Valink can build thousands of drug candidates in days …See details»
Valink Therapeutics - LinkedIn
Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid ...See details»
Valink Therapeutics - Crunchbase Company Profile & Funding
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.See details»
Valink Therapeutics 2025 Company Profile: Valuation, Funding ...
Valink Therapeutics General Information Description. Developer of a modular protein platform designed to facilitate the scalable discovery of bi-specific biologics. The company's platform …See details»
Valink Therapuetics - Hoxton Ventures
Valink Therapeutics (fka LiliumX) is a London-based spinout of the University of Oxford, focused on the development of next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by …See details»
Valink Therapeutics - 2025 Company Profile - Tracxn
Apr 3, 2025 *****@valinktx.com. Key Metrics. Founded Year. 2020. Location. London, United Kingdom. Stage. Funding Raised. Investors. Oxonian Ventures & 1 more. Ranked. 1332 nd …See details»
Team - Valink
Arne Scheu. CEO & Director. Arne Scheu is Co-Founder and CEO of Valink Therapeutics. Following his research on protein conjugation technologies at the University of Oxford, he …See details»
Valink Therapeutics - Y Combinator
Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at …See details»
Valink Therapeutics Appoints Biopharmaceutical Veteran Martin D ...
Dec 18, 2024 The company is based in Boston, Massachusetts and has research and development operations in London, UK. For more information, visit the company’s website at …See details»
Valink Therapeutics on LinkedIn: LiliumX is now called Valink ...
LiliumX is now called Valink Therapeutics! We are proud to unveil our new website and brand identity as Valink Therapeutics, signifying our transition from a platform-building company to a ...See details»
Valink Therapeutics (fka LiliumX) - VentureRadar
Website: https://www.valinktx.com/ Develops advanced therapeutics using proprietary LiliumX™ platform, focusing on innovative antibody engineering and combinatorial ...See details»
Valink Therapeutics - Drug pipelines, Patents, Clinical trials - Synapse
Jun 27, 2024 Explore Valink Therapeutics with its drug pipeline, therapeutic area, technology platform, .See details»
Valink Therapeutics - Products, Competitors, Financials, Employees ...
Dec 19, 2024 Valink Therapeutics Appoints Martin D. Williams as Chair of the Board of Directors. Dec 19, 2024. December 18, 2024 Martin D. Williams BOSTON–( BUSINESS WIRE …See details»
Arne Scheu’s Post - LinkedIn
It's official: We've announced our recent fundraising and rebranded from LiliumX to Valink Therapeutics! Welcome to our new investors, directors and team… | 23 comments on …See details»
Valink | Building new cures from known antibodies - valinktx.com
Rapid Design. The discovery of bsADCs is held back by an inability to rapidly generate and screen new therapeutic candidates. Valink can build thousands of drug candidates in days …See details»
LiliumX unveils rebrand as Valink Therapeutics and appointment …
LiliumX, an innovative BioTech start-up focused on the development of next generation antibody-based therapeutics, has unveiled its new brand name, and welcomed three top industry …See details»
Valink Therapeutics (fka LiliumX) | VentureRadar
Similar Companies: Valink Therapeutics Unknown Privately Held Valink is a technology company that specializes in the creation of drug candidates with bespoke geometries and target …See details»
Valink Therapeutics unveils new brand identity - LinkedIn
CAR-T biotech Cargo Therapeutics prices $281M IPO The offering is one of the largest for a biotech company in 2023, a year that has otherwise been sluggish for drugmaker IPOs.See details»
LiliumX unveils rebrand as Valink Therapeutics and appointment …
Nov 9, 2023 For more information, visit: www.valinktx.com. Post navigation. Chain mediation model of consultation empathy, resilience and resignation coping on depression: a cross …See details»
Valink | Building new cures from known antibodies - valinktx.com
Better Cures. We focus on treating solid tumours with bispecific antibody-drug conjugates. Aiming at two cellular markers at once to differentiate malignant from healthy tissue – this enables us …See details»